Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

NCT06217120 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction
Microvascular Coronary Artery Disease

Interventions

DRUG: Colchicine
DRUG: Placebo

Sponsor

Montreal Heart Institute